NRNatasha Ristovska

Natasha Ristovska

*This is an algorithmically generated author record based on publicly available information.

Natasha Ristovska has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Systemic Barriers and Innovation Pathways for Europe’s Circular Bioeconomy: Grassroots Stakeholder Insights from 43 Multi-Actor Workshops

    by Bas Paris, Athanasios T. Balafoutis, Clio Christopoulou, JoÃO Roberto Fernandes Santos, Natasha Ristovska, Luka Juvančič, Maja Berden Zrimec, Boglárka Vajda, Dimitris Michas, George Papadakis

    The bioeconomy is a key pillar of the European Green Deal, yet its implementation remains constrained by entrenched linear value chains, fragmented logistics systems, and regulatory uncertainty. This paper examines how practitioners across Europe envision circular bioeconomy transitions, drawing on evidence from 43 harmonised multi-actor workshops conducted in 14 countries with 1,078 participants from primary production, processing industries, technology provision, public authorities, and civil society. Using a structured participatory canvas and comparative thematic analysis, we analyse how stakeholders redesign existing value chains, which innovation pathways they prioritise, and which barriers they encounter in practice. Across agriculture, forestry, aquatic systems and bio-based industries, stakeholders consistently shift the focus from expanding biomass production toward improving the use of existing residues and side-streams. Dominant innovation pathways include residue valorisation, nutrient and water recycling, integrated bioenergy systems, and emerging biomaterials. At the same time, four interlinked barrier domains recur across countries and sectors: high and uncertain costs, immature or inaccessible technologies, weak feedstock logistics and pre-treatment infrastructure, and misaligned or unclear regulatory frameworks—most notably around waste and by-product classification. By providing one of the most extensive cross-country, practitioner-led analyses of circular bioeconomy value chains to date, the study offers granular evidence on how regulatory ambiguity, infrastructure gaps and investment risk constrain implementation on the ground. The findings point to a policy agenda focused on regulatory clarification rather than deregulation, coordinated investment in residue aggregation and pre-treatment infrastructure, and applied context-sensitive research to support scalable circular bio-based solutions.